One-Year Healthcare Utilization and Expenditures Among Patients with Clinically Significant Mitral Regurgitation in Taiwan
Abstract Introduction Mitral regurgitation (MR) is characterized by systolic blood flow reversal from the left ventricle to the left atrium. A 2019 study indicated that in the USA, clinically significant MR (sMR) is associated with a substantial healthcare cost burden. In Taiwan, few data are availa...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Adis, Springer Healthcare
2022-12-01
|
| Series: | Cardiology and Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s40119-022-00294-2 |
| _version_ | 1797863255069163520 |
|---|---|
| author | Ching-Hu Chung Yu-Jen Wang Chia-Ying Lee |
| author_facet | Ching-Hu Chung Yu-Jen Wang Chia-Ying Lee |
| author_sort | Ching-Hu Chung |
| collection | DOAJ |
| description | Abstract Introduction Mitral regurgitation (MR) is characterized by systolic blood flow reversal from the left ventricle to the left atrium. A 2019 study indicated that in the USA, clinically significant MR (sMR) is associated with a substantial healthcare cost burden. In Taiwan, few data are available to describe the clinical characteristics, treatment patterns, and economic burden of patients with sMR. Methods Using the National Health Insurance Research Database (NHIRD), a national, detailed claims database of all 23 million residents of Taiwan, we conducted a retrospective cohort study to identify patients with sMR and quantify the impact of the disease on Taiwan’s healthcare system. We classified patients with sMR into three cohorts based on disease etiology: functional MR (sFMR), degenerative MR (sDMR), and uncharacterized MR (sUMR). Results We compared patient characteristics across cohorts and estimated attributable healthcare utilization and costs during the 12-month follow-up period. Our research shows that in Taiwan, patients with sFMR were older, sicker, and presented at casualty (emergency department) more frequently than those with sDMR and sUMR. Meanwhile, patients with sDMR had the highest 12-month healthcare expenditures across the cohorts. Conclusion These findings are inconsistent with what has been shown in the USA, which warrants further investigation. |
| first_indexed | 2024-04-09T22:32:36Z |
| format | Article |
| id | doaj.art-3452961d9205428ea40d41badb41be62 |
| institution | Directory Open Access Journal |
| issn | 2193-8261 2193-6544 |
| language | English |
| last_indexed | 2024-04-09T22:32:36Z |
| publishDate | 2022-12-01 |
| publisher | Adis, Springer Healthcare |
| record_format | Article |
| series | Cardiology and Therapy |
| spelling | doaj.art-3452961d9205428ea40d41badb41be622023-03-22T12:39:31ZengAdis, Springer HealthcareCardiology and Therapy2193-82612193-65442022-12-0112115916910.1007/s40119-022-00294-2One-Year Healthcare Utilization and Expenditures Among Patients with Clinically Significant Mitral Regurgitation in TaiwanChing-Hu Chung0Yu-Jen Wang1Chia-Ying Lee2Department of Medicine, Mackay Medical CollegeEdwards Lifesciences (Taiwan) CorpEdwards Lifesciences (Taiwan) CorpAbstract Introduction Mitral regurgitation (MR) is characterized by systolic blood flow reversal from the left ventricle to the left atrium. A 2019 study indicated that in the USA, clinically significant MR (sMR) is associated with a substantial healthcare cost burden. In Taiwan, few data are available to describe the clinical characteristics, treatment patterns, and economic burden of patients with sMR. Methods Using the National Health Insurance Research Database (NHIRD), a national, detailed claims database of all 23 million residents of Taiwan, we conducted a retrospective cohort study to identify patients with sMR and quantify the impact of the disease on Taiwan’s healthcare system. We classified patients with sMR into three cohorts based on disease etiology: functional MR (sFMR), degenerative MR (sDMR), and uncharacterized MR (sUMR). Results We compared patient characteristics across cohorts and estimated attributable healthcare utilization and costs during the 12-month follow-up period. Our research shows that in Taiwan, patients with sFMR were older, sicker, and presented at casualty (emergency department) more frequently than those with sDMR and sUMR. Meanwhile, patients with sDMR had the highest 12-month healthcare expenditures across the cohorts. Conclusion These findings are inconsistent with what has been shown in the USA, which warrants further investigation.https://doi.org/10.1007/s40119-022-00294-2Mitral valve diseaseValvular diseaseHeart valve diseaseFunctional mitral regurgitationDegenerative mitral regurgitationUncharacterized mitral regurgitation |
| spellingShingle | Ching-Hu Chung Yu-Jen Wang Chia-Ying Lee One-Year Healthcare Utilization and Expenditures Among Patients with Clinically Significant Mitral Regurgitation in Taiwan Cardiology and Therapy Mitral valve disease Valvular disease Heart valve disease Functional mitral regurgitation Degenerative mitral regurgitation Uncharacterized mitral regurgitation |
| title | One-Year Healthcare Utilization and Expenditures Among Patients with Clinically Significant Mitral Regurgitation in Taiwan |
| title_full | One-Year Healthcare Utilization and Expenditures Among Patients with Clinically Significant Mitral Regurgitation in Taiwan |
| title_fullStr | One-Year Healthcare Utilization and Expenditures Among Patients with Clinically Significant Mitral Regurgitation in Taiwan |
| title_full_unstemmed | One-Year Healthcare Utilization and Expenditures Among Patients with Clinically Significant Mitral Regurgitation in Taiwan |
| title_short | One-Year Healthcare Utilization and Expenditures Among Patients with Clinically Significant Mitral Regurgitation in Taiwan |
| title_sort | one year healthcare utilization and expenditures among patients with clinically significant mitral regurgitation in taiwan |
| topic | Mitral valve disease Valvular disease Heart valve disease Functional mitral regurgitation Degenerative mitral regurgitation Uncharacterized mitral regurgitation |
| url | https://doi.org/10.1007/s40119-022-00294-2 |
| work_keys_str_mv | AT chinghuchung oneyearhealthcareutilizationandexpendituresamongpatientswithclinicallysignificantmitralregurgitationintaiwan AT yujenwang oneyearhealthcareutilizationandexpendituresamongpatientswithclinicallysignificantmitralregurgitationintaiwan AT chiayinglee oneyearhealthcareutilizationandexpendituresamongpatientswithclinicallysignificantmitralregurgitationintaiwan |